TBRIF (Therma Bright) Inventories, Finished Goods : $0.13 Mil (As of Oct. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Therma Bright Inventories, Finished Goods?

Therma Bright's quarterly finished goods declined from Apr. 2024 ($0.13 Mil) to Jul. 2024 ($0.00 Mil) but then increased from Jul. 2024 ($0.00 Mil) to Oct. 2024 ($0.13 Mil).

Therma Bright Inventories, Finished Goods Historical Data

The historical data trend for Therma Bright's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therma Bright Inventories, Finished Goods Chart

Therma Bright Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Inventories, Finished Goods

Get a 7-Day Free Trial

Therma Bright Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Inventories, Finished Goods	Get a 7-Day Free Trial															0.13	0.13	0.13	-	0.13

Therma Bright Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Therma Bright Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Therma Bright Inc (OTCPK:TBRIF) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

JNX:Germany THRM:Canada

Address

345 Danforth Avenue, Toronto, ON, CAN, M4K 1N7

Website

https://www.thermabright.com

Therma Bright Inc is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on 3 key strategic areas: respiratory disease, vascular health, and consumer medical devices.